Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening Familial Risk for Hereditary Breast and Ovarian Cancer.

JAMA network open - 3 Sept 2024

Kiser Daniel, Elhanan Gai, Bolze Alexandre, Neveux Iva, Schlauch Karen A, Metcalf William J, Cirulli Elizabeth T, McCarthy Catherine, Greenberg Leslie A, Grime Savanna, Blitstein Jamie M Schnell, Plauth William, Grzymski Joseph J

Abstract excerpt

Importance: Most patients with pathogenic or likely pathogenic (P/LP) variants for breast cancer have not undergone genetic testing. Objective: To identify patients meeting family history criteria for genetic testing in the electronic health record (EHR). Design, Setting, and Participants: This study included both cross-sectional (observation date, February 1, 2024) and retrospective cohort (observation period,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Fanconi Anemia Complementation Group N Protein

Share to Genetic Testing

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Ovarian Neoplasms

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39320887
DOI: 10.1001/jamanetworkopen.2024.35901
PMCID: PMC11425146

Genes

BRCA1
BRCA2
CHEK2
PALB2
ATM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening Familial Risk for Hereditary Breast and Ovarian Cancer.PMID 39320887Read ↗

Combining rare and common genetic variants improves population risk stratification for breast cancerSemantic proximity Read ↗

Hereditary cancer testing in a diverse sample across three breast imaging centers.Semantic proximity Read ↗

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer PatientsSemantic proximity Read ↗

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer.Semantic proximity Read ↗

The Potential of Genetics in Identifying Women at Lower Risk of Breast CancerSemantic proximity Read ↗

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.Semantic proximity Read ↗

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Semantic proximity Read ↗

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.